Piramal Finishes First Phase of Sterile Manufacturing Expansion
Part of the special news roundup of DCAT member companies for the DCAT Week ’17 Special Edition of DCAT Value Chain Insights (April 5, 2017)
Piramal Pharma Solutions, a contract service provider providing development and manufacturing services, has completed Phase I of a previously announced, two-phase expansion of its sterile manufacturing capabilities at its facilities in Lexington, Kentucky. The $25 million investment, announced in August 2016, will increase Piramal’s capacity and capabilities in manufacturing and is being rolled out in phases.
The now completed Phase I expansion includes the installation of a new high-speed vial filling line, expansion of laboratories, and associated utility support. The new filling line will double the capacity at Lexington and will enhance efficiency and productivity. A portion of the new capacity has been committed to supporting commercial product launches.
The next phase of expansion, which includes expanding lyophilization capability, will begin immediately, and is expected to be operational by the end of 2018.
Source: Piramal Pharma Solutions